157 related articles for article (PubMed ID: 24680582)
1. Recommendations for scale-up of community-based misoprostol distribution programs.
Robinson N; Kapungu C; Carnahan L; Geller S
Int J Gynaecol Obstet; 2014 Jun; 125(3):285-8. PubMed ID: 24680582
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
[TBL] [Abstract][Full Text] [Related]
3. Postpartum hemorrhage prevention in Nepal: a program assessment.
Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B
BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092
[TBL] [Abstract][Full Text] [Related]
4. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia.
Smith JM; Baawo SD; Subah M; Sirtor-Gbassie V; Howe CJ; Ishola G; Tehoungue BZ; Dwivedi V
BMC Pregnancy Childbirth; 2014 Jun; 14():189. PubMed ID: 24894566
[TBL] [Abstract][Full Text] [Related]
5. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
[TBL] [Abstract][Full Text] [Related]
6. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence.
Oladapo OT
Int J Gynaecol Obstet; 2012 Nov; 119(2):105-10. PubMed ID: 22968139
[TBL] [Abstract][Full Text] [Related]
7. Effect of community-based distribution of misoprostol on facility delivery: a scoping review.
Tiruneh GT; Yakob B; Ayele WM; Yigzaw M; Roro MA; Medhanyi AA; Hailu EG; Bayou YT
BMC Pregnancy Childbirth; 2019 Nov; 19(1):404. PubMed ID: 31694580
[TBL] [Abstract][Full Text] [Related]
8. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan.
Smith JM; Dimiti A; Dwivedi V; Ochieng I; Dalaka M; Currie S; Luka EE; Rumunu J; Orero S; Mungia J; McKaig C
Int J Gynaecol Obstet; 2014 Nov; 127(2):183-8. PubMed ID: 25051905
[TBL] [Abstract][Full Text] [Related]
9. Misoprostol for the management of postpartum bleeding: a new approach.
Dabash R; Blum J; Raghavan S; Anger H; Winikoff B
Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
Raghavan S; Abbas D; Winikoff B
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
[TBL] [Abstract][Full Text] [Related]
11. Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis.
Sutherland T; Meyer C; Bishai DM; Geller S; Miller S
Int J Gynaecol Obstet; 2010 Mar; 108(3):289-94. PubMed ID: 20079493
[TBL] [Abstract][Full Text] [Related]
12. Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.
Lubinga SJ; Atukunda EC; Wasswa-Ssalongo G; Babigumira JB
PLoS One; 2015; 10(11):e0142550. PubMed ID: 26560140
[TBL] [Abstract][Full Text] [Related]
13. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
Tang J; Kapp N; Dragoman M; de Souza JP
Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
[TBL] [Abstract][Full Text] [Related]
14. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
[TBL] [Abstract][Full Text] [Related]
15. Misoprostol: preventing postpartum haemorrhage.
Walder J
Mod Midwife; 1997 Sep; 7(9):23-7. PubMed ID: 9370621
[TBL] [Abstract][Full Text] [Related]
16. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal.
Rajbhandari S; Hodgins S; Sanghvi H; McPherson R; Pradhan YV; Baqui AH;
Int J Gynaecol Obstet; 2010 Mar; 108(3):282-8. PubMed ID: 20034628
[TBL] [Abstract][Full Text] [Related]
17. Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework.
Hobday K; Hulme J; Prata N; Wate PZ; Belton S; Homer C
Glob Health Sci Pract; 2019 Mar; 7(1):66-86. PubMed ID: 30926738
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different models of access to misoprostol at the community level to improve maternal health outcomes in Ethiopia, Ghana, and Nigeria.
Wells E; Coeytaux F; Azasi E; Danmusa S; Geressu T; McNally T; Potts J; Otive-Igbuzor E; Tibebu S
Int J Gynaecol Obstet; 2016 Jun; 133(3):261-5. PubMed ID: 27158098
[No Abstract] [Full Text] [Related]
19. Community-based availability of misoprostol: is it safe?
Prata N; Mbaruku G; Grossman AA; Holston M; Hsieh K
Afr J Reprod Health; 2009 Jun; 13(2):117-28. PubMed ID: 20690255
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol: an essential medicine for managing postpartum hemorrhage in low-resource settings?
Rushwan H
Int J Gynaecol Obstet; 2011 Sep; 114(3):209-10. PubMed ID: 21745664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
